1. Home
  2. GL vs RDY Comparison

GL vs RDY Comparison

Compare GL & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Globe Life Inc.

GL

Globe Life Inc.

HOLD

Current Price

$138.82

Market Cap

11.3B

Sector

Finance

ML Signal

HOLD

Logo Dr. Reddy's Laboratories Ltd

RDY

Dr. Reddy's Laboratories Ltd

HOLD

Current Price

$14.12

Market Cap

11.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GL
RDY
Founded
1900
1984
Country
United States
India
Employees
3732
N/A
Industry
Life Insurance
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.3B
11.6B
IPO Year
N/A
2001

Fundamental Metrics

Financial Performance
Metric
GL
RDY
Price
$138.82
$14.12
Analyst Decision
Buy
Strong Buy
Analyst Count
11
1
Target Price
$166.18
$16.90
AVG Volume (30 Days)
403.3K
1.7M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
0.78%
0.50%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$9.60
$7.50
Revenue Next Year
$5.54
$2.96
P/E Ratio
$10.21
$18.67
Revenue Growth
N/A
N/A
52 Week Low
$109.38
$12.26
52 Week High
$152.71
$16.17

Technical Indicators

Market Signals
Indicator
GL
RDY
Relative Strength Index (RSI) 37.93 45.56
Support Level $135.08 $14.07
Resistance Level $143.04 $14.14
Average True Range (ATR) 2.96 0.22
MACD -0.78 -0.05
Stochastic Oscillator 5.26 16.05

Price Performance

Historical Comparison
GL
RDY

About GL Globe Life Inc.

Globe Life Inc is an insurance holding company. It provides a variety of life and supplemental health insurance products and annuities to a broad base of customers. The company's core operations are organized into three reportable segments: life insurance, supplemental health insurance and investments. Investment activities, conducted by the investment segment, focus on seeking investments with a yield and term appropriate to support the insurance product obligations. These investments generally consist of fixed maturities and, over the long term, the expected yields are considered when setting insurance premium rates and product profitability expectations.

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: